New chemical modification improves effectiveness and safety of ASO therapy for CNS diseases

FHS
May 23, 2024
2:48 pm

Diseases that affect the brain and spinal cord can be particularly devastating, and finding new and more effective ways to treat these conditions is an important goal for researchers and clinicians alike.

New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Results

Two-thirds of cancer drugs approved by the European Medicines Agency from 1995 to 2020 had little or no supporting evidence of added clinical benefit, particularly

March 2, 2024

Phase III trials indicate reversible cognitive side effects in brain metastases treatment

A substantial number of patients with brain metastases who experience cognitive side effects following radiation therapy may fully regain cognitive function, according to a pooled

September 30, 2024

Can you rely on your mammogram to identify heart disease risk?

When people check in for their annual mammogram these days, some may face a surprising question: In addition to reviewing the mammogram for breast cancer,

October 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.